These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 5879371)

  • 21. Ifosfamide in the treatment of ovarian cancer.
    Markman M
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):47-9. PubMed ID: 8677449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of chemotherapy in gynecologic cancer.
    Tropé C; Kristensen G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy for recurrent or advanced persistent epithelial ovarian cancer].
    Edelman DZ; Anteby SO; Peretz T
    Harefuah; 1996 Jul; 131(1-2):31-6. PubMed ID: 8854476
    [No Abstract]   [Full Text] [Related]  

  • 24. Investigational agents for epithelial ovarian cancer.
    Muggia F; Kosloff R
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):855-68. PubMed ID: 16221055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH
    Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemoresistance in ovarian cancer. State of the art and future prospects].
    Katsaros D; Fracchioli S; Arese P; Enria R; Cassinelli P; Mingrone K; Piccinno R; Rigault de la Longrais IA; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):483-99. PubMed ID: 10767997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial ovarian cancer: second and third line chemotherapy (review).
    Latorre A; De Lena M; Catino A; Crucitta E; Sambiasi D; Guida M; Misino A; Lorusso V
    Int J Oncol; 2002 Jul; 21(1):179-86. PubMed ID: 12063566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cancer.
    Gabra H; Redman C; Byrom J
    Clin Evid; 2002 Dec; (8):1951-63. PubMed ID: 12603978
    [No Abstract]   [Full Text] [Related]  

  • 30. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.
    Rao G; Crispens M; Rothenberg ML
    J Clin Oncol; 2007 Jul; 25(20):2867-72. PubMed ID: 17617517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian cancer: a brief overview.
    Padilla F; Gilliam C
    J Ark Med Soc; 1988 Jan; 84(8):339-41. PubMed ID: 2963804
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combined chemotherapy of neglected form of ovarian cancer].
    Baksheeva AO
    Pediatr Akus Ginekol; 1965; 1():37-9. PubMed ID: 5879371
    [No Abstract]   [Full Text] [Related]  

  • 33. Ovarian cancer.
    Gabra H; Redman C; Byrom J
    Clin Evid; 2003 Dec; (10):2170-83. PubMed ID: 15555197
    [No Abstract]   [Full Text] [Related]  

  • 34. Ovarian cancer.
    Oates-Whitehead R
    Clin Evid; 2004 Jun; (11):2493-506. PubMed ID: 15652119
    [No Abstract]   [Full Text] [Related]  

  • 35. Epithelial ovarian cancer: Does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance?
    Larsen E; Blaakaer J
    Acta Obstet Gynecol Scand; 2009; 88(4):373-7. PubMed ID: 19253061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for ovarian cancer: an evidence-based approach.
    Geisler JP; Manahan KJ; Wiemann MC
    Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.